JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $491,400 | -10.2% | 48,750 | +5.7% | 0.00% | – |
| Q2 2023 | $547,456 | -0.3% | 46,121 | +1.6% | 0.00% | – |
| Q1 2023 | $549,243 | -12.6% | 45,392 | -4.8% | 0.00% | – |
| Q4 2022 | $628,077 | -0.5% | 47,690 | +2.4% | 0.00% | – |
| Q3 2022 | $631,000 | +21.3% | 46,563 | +9.5% | 0.00% | – |
| Q2 2022 | $520,000 | -18.4% | 42,510 | -4.3% | 0.00% | – |
| Q1 2022 | $637,000 | -4.9% | 44,400 | +30.8% | 0.00% | – |
| Q4 2021 | $670,000 | -5.0% | 33,946 | +4.2% | 0.00% | – |
| Q3 2021 | $705,000 | – | 32,576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |